Cargando…
The Efficacy and Safety of Mirabegron for the Treatment of Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review and Meta-analysis
Background and Objective: Over the past few years, mirabegron has been increasingly used as a therapeutic option for neurogenic lower urinary tract dysfunction. Here, we carried out a meta-analysis to investigate the efficacy and safety of mirabegron for the treatment of neurogenic lower urinary tra...
Autores principales: | Zhang, Dongxu, Sun, Fengze, Yao, Huibao, Bao, Xingjun, Wang, Di, Cui, Yuanshan, Wu, Jitao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636815/ https://www.ncbi.nlm.nih.gov/pubmed/34867373 http://dx.doi.org/10.3389/fphar.2021.756582 |
Ejemplares similares
-
Efficacy and Safety of Combination Comprising Tamsulosin and PDE5-Is, Relative to Monotherapies, in Treating Lower Urinary Tract Symptoms and Erectile Dysfunction Associated With Benign Prostatic Hyperplasia: A Meta-Analysis
por: Sun, Kai, et al.
Publicado: (2020) -
The Efficacy and Safety of HoLEP for Benign Prostatic Hyperplasia With Large Volume: A Systematic Review and Meta-Analysis
por: Sun, Fengze, et al.
Publicado: (2022) -
Generation of Urothelial Cells from Mouse-Induced Pluripotent Stem Cells
por: Zhang, Dongxu, et al.
Publicado: (2022) -
Efficacy and Adverse Events of PD-1 Inhibitors in Patients With Advanced Urothelial Carcinoma From a Real-World Experience
por: Sun, Fengze, et al.
Publicado: (2022) -
Adverse Effects and Toxicity of Immune Checkpoint Inhibitors For Patients With Urothelial Carcinoma
por: Wang, Di, et al.
Publicado: (2021)